Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of a new nasal spray formulation of Argotone in healthy volunteers
2005-005576-32Phase 2Completed
- Sponsor
- Bracco Group
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ephedrine in rhinitis and nasal congestion, sponsored by Bracco Group. Primary endpoints: Systemic blood pressure, Ocular tone and 2 more. Started Feb 2006; status: completed.
02
Drugs
ephedrine
03
Conditions
rhinitisnasal congestion
Beyond the preview
Go deeper on 2005-005576-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005576-32.